The groundbreaking medication, Mounjaro, is sparking considerable excitement within the medical community as a possible tool for treating Adult-Onset Metabolic Disorder. Unlike some traditional therapies , Mounjaro utilizes a dual action , targeting both GLP-1 receptors and the GIP receptor, leading to better glycemic regulation and, in some studie